Skip to main content

NEW MEDICAL DEVICE REGULATION(MDR): TOP 5 CHALLENGES


Within the medical devices industry, professionals have long been exercising acquiescence with regards to the new European Medical Device Regulation (MDR). At last, after a very lengthy process the MDR was finalized and it was duly published in the Official Journal of the European Union on 5th May, 2017.


           
With the passing of the new MDR, the previous regulations viz., the Active Implantable Medical Device Directive (90/385/EEC) as well as the Medical Device Directive has been totally replaced. The primary objective of the Revision of Medical Device Regulation is to ensure a regulatory framework that is sustainable, forceful, foreseeable and clear which is essential for ensuring that the level of safety is
extremely high within the healthcare sector and at the same time fosters innovation

Guidance to Medical Device Regulations in Europe

To highlight the key modifications that have been effected by the new MDR and to resolve these issues, the top five hurdles that device manufacturers will need to take care once the transition period of the new MDR is over, has been outlined as under:


Top 5 Challenges are:

1) Reclassification
2) Market Access of Legacy Products
3) Reprocessing Single Use Device
4) Technical Documentation
5) Clinical Evaluation

To know how to handle and resolve this issues click here

About Author
Dr.Nancy,
Editor-in-chief,
Medical Writing Experts.

Contact us:US/Canada: +1-972-502-9262UK: +44-1143520021India: +91-8754446690Email: info@medicalwritingexperts.comWeb: Medical Writing ExpertsWatch Video: https://youtu.be/0iufe_0evt8

Labels:

Comments

Post a Comment

Popular posts from this blog

NEVER MISS THESE WHILE WRITING THE “COMMON TECHNICAL DOCUMENT (CTD) FOR PHARMACEUTICAL”

Scientific Regulatory writing  is a complex process due to its dossier size, data complexity, and submission deadlines and it requires specialized domain-specific knowledge, understanding of drug development process, pharmacology, statistical and writing skills to develop superior regulatory documents as per the exact requirements of the regulatory authority. Besides, the scientific writer must be familiar with technical guidelines prevailing in countries like European Union (EU), USA, Japan that includes ICH E3 to write clinical study reports, periodic safety reports (ICH E2C), publication guidelines (e.g. CONSORT, STROBE, PRISMA), the International Committee of Medical Journal Editors (ICMJE) guidelines for manuscripts. Common Technical Document(CTD) for Pharmaceutical The Common Technical Document (CTD) is an international standard for the summary documents relating to quality, safety and efficacy information of medicinal products. The CTD is mandatory for the registr...
Post a Comment
Read more

WRITING MEDICAL CONTENT FOR CLINICAL RESEARCH-QUICK GUIDE FOR CLINICAL PRACTITIONERS AND RESEARCHERS

Medical content Writing  is an integral component of clinical research that is essential for effectively taking research related scientific communications to the target audience like medical specialists and health care professionals. Effective and well-structured medical contents with appropriate research design and reference support is imperative for every aspiring medical researcher to publish their clinical research studies in reputed national and international medical journals. Click Here to know more...
Post a Comment
Read more

CHALLENGES IN THE CRO INDUSTRY: SELECTING A CRO FOR YOUR RESEARCH TRIALS

Clinical Research Organization for Healthcare  provides clinical-study and clinical-trial support for drugs and medical devices, wherein many pharmaceuticals, biotechnology, and medical device industries having operations in the Europe Union states outsource research services to CRO to increase efficiency and improve productivity. Clinical Research Organization | PEPGRA Contract Research Organization for Pharmaceutical Industry  offer services such as Project, Data and Regulatory Management; Contracting; Medical Writing; and Site and Medical Monitoring, which offers the comprehensive benefits for pharmaceutical companies in Europe Union to make clinical research trials more efficient and cost-effective in testing economic period. CRO   industry Challenges The CRO faces multifaceted challenges in the form of Increasingly becoming complex nature of regulatory requirements, GxP compliance, and quality. High levels of risk associated with the CRO business...
Post a Comment
Read more